We report a case of vitiligo that occurred during the second month of interferon alpha 2a therapy for chronic active hepatitis C. The patient received the interferon for four months.
|Original language||English (US)|
|Number of pages||2|
|State||Published - Dec 1 1997|
ASJC Scopus subject areas